Skip to content
64x Bio logo

64x Bio

64x Bio is a YC Summer 2018 (S18) company. Based in San Francisco, CA, USA. Team of 25.

  • Gene Therapy
  • Machine Learning

About 64x Bio

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

64x Bio engineers high-yield cell lines and production technologies for gene and cell therapy manufacturers hitting manufacturing bottlenecks. Its VectorSelect platform combines massively parallelized screening with computational analysis to optimize viral vector and biologic production systems, covering AAV, lentiviral, and protein therapeutics. The work replaces slow, low-throughput cell line development that constrains the scale-up of advanced therapies.

Business model

Licensing of high-performing cell lines and cell line optimization services through the Apex Suites and VectorSelect platform

Go-to-market

Biopharmaceutical and cell and gene therapy developers license cell lines or engage 64x Bio for cell line optimization directly through its Apex Suite product lines and VectorSelect platform partnerships.

From the Y Combinator listing

How 64x Bio describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Enabling next generation medicines. A comprehensive platform and…

The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up. Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.

Facts

Industry
Healthcare / Healthcare -> Industrial Bio
Location
San Francisco, CA, USA
Team size
25
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works